Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Liver Physiology01:30

Liver Physiology

4.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.5K
Teratogenicity01:07

Teratogenicity

4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

358
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenosine A2B Receptor Activation: A Novel Therapeutic Strategy for Accelerating Liver Recovery After Acetaminophen Overdose.

bioRxiv : the preprint server for biology·2026
Same author

Rational Prescribing Under Pressure: A World Health Organization Indicator and National Medical Commission Compliance Audit With Shift-Based Analysis of Emergency Prescriptions at a Tertiary Care Hospital in North India.

Cureus·2026
Same author

Differentiating Hepatic and Renal Toxicity Reveals CYP-Independent Mechanisms of Acetaminophen-Induced Acute Kidney Injury.

bioRxiv : the preprint server for biology·2026
Same author

Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.

Gut·2026
Same author

Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Primary ciliary dyskinesia in pediatric persons: A microscopic movement malady.

Disease-a-month : DM·2026

Related Experiment Video

Updated: Apr 16, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.2K

Pregnancy-related liver disorders.

Ashish Goel1, Kapil D Jamwal1, Anup Ramachandran2

  • 1Department of Hepatology, Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, Tamil Nadu, India.

Journal of Clinical and Experimental Hepatology
|March 11, 2015
PubMed
Summary

Pregnancy-related liver disorders, including AFLP and HELLP syndrome, contribute to maternal deaths. Early diagnosis and management are crucial for improving outcomes in these serious conditions.

Keywords:
AFLP, acute fatty liver of pregnancyCS, CaesareanFAO, fatty acid oxidationHELLP syndromeHELLP, hemolysis elevated liver enzymes and low plateletsHG, hyperemesis gravidarumHbsAg, hepatitis B surface antigenICP, intrahepatic cholestasis of pregnancyLCHAD, long chain hydroxyacyl coA dehydrogenaseLDH, lactate dehydrogenaseLFT, liver function testsMP, malarial parasiteMTP, mitochondrial tri-functional proteinPFIC, progressive familial intra-hepatic cholestasisPRLD, pregnancy-related liver disordersPT, prothrombin timeUDCA, ursodeoxycholic acidacute fatty liver of pregnancymaternal mortalitypre-eclampsia

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

15.3K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K

Related Experiment Videos

Last Updated: Apr 16, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

31.2K
Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

15.3K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K

Area of Science:

  • Obstetrics and Gynecology
  • Hepatology
  • Maternal-Fetal Medicine

Background:

  • Pregnancy-associated liver conditions represent a significant cause of maternal morbidity and mortality.
  • Acute fatty liver of pregnancy (AFLP), HELLP syndrome, and pre-eclamptic liver dysfunction are key disorders.
  • AFLP is frequently underdiagnosed, complicating timely intervention.

Purpose of the Study:

  • To review the key aspects of pregnancy-related liver disorders.
  • To emphasize the importance of early recognition and multi-specialty management.
  • To discuss advancements in understanding and managing these conditions.

Main Methods:

  • Literature review focusing on pregnancy-related liver disorders.
  • Analysis of incidence and outcomes of AFLP, HELLP syndrome, and pre-eclamptic liver dysfunction.
  • Discussion of diagnostic challenges and therapeutic strategies.

Main Results:

  • Pregnancy-related liver disorders comprised 8% of maternal deaths at the center (1999-2011).
  • Timely recognition and aggressive management can minimize maternal mortality risks.
  • Urgent termination of pregnancy is a critical treatment for certain severe cases.

Conclusions:

  • Effective management of pregnancy-related liver disorders requires prompt diagnosis and coordinated care.
  • Continued research and understanding are vital for optimizing patient outcomes.
  • Addressing underdiagnosis, particularly of AFLP, is essential for reducing maternal mortality.